There are no announcements yet.
Human immunodeficiency virus, or HIV, is the virus that causes acquired immune deficiency syndrome (AIDS). The virus weakens a person’s immune system so they are not able to fight infections or cancer as effectively. Having HIV does not always mean you have AIDS, as it can take many years for people with HIV to develop AIDS.
HIV targets a type of white blood cell called a CD4 cell, which it attacks and destroys. CD4 cells are important for fighting disease, and when a person’s CD4 cell count is too low, they are more susceptible to illness.
HIV is contracted when infected bodily fluids such as blood, semen, fluids from the vagina, or breast milk enter a person’s blood stream. It is commonly a sexually transmitted disease, but can occur when needles are not cleaned properly or are shared. It can also enter the body through broken skin. In addition, a pregnant woman with HIV can spread the virus to her baby.
Symptoms of HIV generally appear after a person’s immune system has been weakened. The symptoms are:
Fatigue and lack of energy
Unexplained weight loss
Frequent fevers or sweats
Persistent or frequent yeast infections
Persistent skin rashes
Short term memory loss
Mouth, genital, or anal sores from herpes infections
Once a person develops AIDS, meaning their CD4+ cell count is below 200 per microliter of blood, the whole body and nearly every organ can be affected. The person can have the following symptoms:
Cough/shortness of breath
Seizures
Difficult or painful swallowing
Mental symptoms (confusion, forgetfulness)
Severe and persistent diarrhea
Fever
Vision loss
Nausea, abdominal cramps, bloating
Weight loss and extreme fatigue
Severe headaches
Coma
HIV/AIDS medications are very powerful and often produce powerful side effects. They include:
Anemia
Diarrhea and abdominal pain
Nausea
Vomiting
Fatigue
Dizziness
Chills
Anxiety
Rash
Depression
Difficulty sleeping
Headache
While the effects of cannabinoids have not been studied for all of these symptoms and side effects, there are many reports that cannabinoids can be beneficial, either lessening the symptoms of the disease itself, or the side effects of the medication. Cannabinoid solutions seems to have a positive effect on stomach upset, abdominal pain, nausea/vomiting, difficulty sleeping, anxiety, and headaches.
In addition, TAT (Trans-Activator of Transcription), an HIV gene, has been shown by researchers at the Mount Sinai School of Medicine to be inhibited by cannabinoids. HIV has been able to mutate and reproduce itself despite the use of antiretroviral drugs. Soon, the HIV in countless numbers of patients will be resistant to conventional treatments, a huge problem for the whole world. Cannabis Science has begun a drug development program to target this problem, using cannabinoids to inhibit TAT.
Cannabis Sciences’s work with cannabinoids in relation to HIV/AIDS will create more scientific studies and information for the public and medical community’s general knowledge about cannabinoid solutions.
*** Warning this document contains graphic images.
Click the above Image to Review our Cancer Drug Comparables
Click the above Image to Review our 1-Million Strong FC, Media Kit
*** Warning this document contains exciting images.
Click the surrounding Images to become one of the First 1-Million Strong Killing Cancers, Fight Club Members to help 'Make that Change' Join in Now! *** Warning this Membership contains Exciting Results.
PS ... ALL of our CSi-VIP's, CSi-GIFT Share Recipients (Paid Processing Fees), CSi-Award Recipients, and those who Donated through the GO-Fund-Me Promotion are ALL Automatically included as "1-Million Strong Killing Cancers, Fight Club Members!"
You do not need to purchase anything, you are ALREADY included in the "First" 1-Million Membership Club, CONGRATULATIONS !!!
Please Click the Calendar image below to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy".
ALL of your PREVIOUS Cannabis Science (CBIS) Shares are on Record with the Company and with the Transfer Agent (As Confirmed by the SEC).
The Company does NOT have your Original trading CBIS Shares, either you have them, or your Brokerage Firm has them (with new identifier codes) or the Transfer Agent has them.
You can confirm with your Broker (Please obtain an Official Brokerage Firm Letter Representing where your CBIS shares are).
Your CBIS GIFT Shares are on Record Books with the Company and/or in your possesion for Regulatory submissions, Registered Legal Opinion Letters, and awaiting Final Audit for Final Trading approvals.
Your CBIS Shares are legal tender and we are ALL waiting for the FINAL Confirmations for trading once the Audits and Legal Filings are completed.
*** We will announce the FINAL CBIS acquisition changes and Corporate Mergers once the filings are completed, so as long as you know where your CBIS Shares are, you are GOOD.
As clearly stated by Mr. Dabney "Our History is Building up into our Inaugural Event of our Lifetime, the Inaugural 1-Million Strong Killing Cancers, Fight Club, VIP Fundraiser Event, dubbed, 'Celebrities Raising $20 Million to Keep Killing Cancers' the Initiative is fueled further with the '1- Million Strong Killing Cancers, Variety Television Show' through the ASU 'Make that Change Campaign'. Hence the accumulation of 1-Million people donating $20 each, because we are ALL Celebrities in our own Rights.
This is More than enough Funding to begin our FDA Clinical Trials for our 'Low-Cost Cancer Drugs' to treat millions Worldwide that already has proven HARVARD Award Winning Cancer Killing Success!
AND
This is also PLENTY of Funding to bring ALL our CBIS Shares back trading again and follow through with our Original Complete Cannabis Science Share trading Game Plan, and We Win, once again. Hopefully we'll see you at the Event to help 'Make that Change'!"
Should you have any further questions regarding your CBIS Shares or additional Share Ownership, Please Click the above Calendar Link to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy".
The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.
Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.
We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.
Click here to review the Report:
Case No. 2:17-CV-02271-KJM-JDP
Inspire, Dream, Change
YOUR DIGITAL ERA Personal & Business Access Learning HUB
Cannabis Science CEO, Presents …
The FINAL “CBIS GIFT Shares” Issuances!
DECEMBER 1, 2022, Cheers! & HAPPY HOLIDAYS !!!
ALL GIFT Shares 1, 2, & 3 being ISSUED !!!
LAST Steps:
Please confirm Yours NOW !!!
1. CONFIRM Correct Total Share Amount(s)
2. CONFIRM Correct Name(s) on CERTIFICATE
3. CONFIRM Correct Mailing Address
ASU/CSi-EDP-ECO-System
At it's FINEST !!!
WHICH ONE ARE YOU ??
Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???
We can make this HAPPEN way FASTER Working as a TEAM !!!
WHAT Matters is how much you CARE about KILLING CANCERS ...
This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.
2023 Audit considerations NASDAQ.
Cannabis Science Inc.
Share Structure 2023
Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.
Common Stock:
Authorized:
5,000,000,000
Issued:
2,521,095,296
Class A Common Stock
Authorized:
100,000,000
Issued:
0
Class B Common Stock
Authorized:
1,500,000,000
Issued:
0
Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000
Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.
You already know our Extensive LIST of GROUNDBREAKING Products.
1-Million STRONG TV Coverage, HARVARD Award Success.
TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE
*** APPLY for FREE in CONFIDENCE and Success.
Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.
EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!
November 19, 2024, It is CERTAINLY Time for another UPDATE !!!
We've been utterly swamped putting together our 1-Million Strong, VIP Cancer Killing,...November 19, 2024, It is CERTAINLY Time for another UPDATE !!!
We've been utterly swamped putting together our 1-Million Strong, VIP Cancer Killing, Fundraiser Event, organizing all the Big strokes and the Little ones too. We've got a few new Exciting options to announce for the Event that just came in and some new team members coming on board opening new doors to help solidify our Success.
At the same time, we've Successfully lined up our path to trading again, it's all about the money now and has been that way for a minute. However, now that our VIP Cancer Killing Fundraiser Event is taking off on the good foot, we are pushing to receive enough funding for our first FDA Clinical Trials for our Cancer Killing Drugs as well as the capital for the Audits and Legal team to walk (CBIS/CSi) Cannabis Science through to trading on NASDAQ if we so choose that path.
Trading on NASDAQ at this point seems to make the most sense, solidified with our Cancer Drug Valuations coming in over $25 million for each cancer target ready for Pharmacokinetics for the FDA IND# (and we have more than one). We KNOCKED the Ball out of the Park. It's been quite the experience rounding all the bases to get to Homeplate (The FDA and ‘CBIS/CSi’ Trading, and possibly on NASDAQ).
Cheers Guys and CONGRATULATIONS!!
We are FINALLY here, at the Finish line, Ready.
We have Certainly been Blessed to get here.
Thanks for your Patience as we transform all of our (CBIS/CSi) Cannabis Science, ‘Cancer Killing Investments’ into a game changing Financial Success for us all. Your Support has been second to none, you are the reason we made it this far. You are the reason our Cancer Killing Drugs are coming out on the Market and will ‘Change History Worldwide, killing cancers’ even more Success than we already have at HARVARD.
1. Congratulations to ALL our ‘CSI-VIP Legacy Cancer Drug Owners’, you’ve stepped up to the ‘Highest Level’ and you deserve the Special Ownership Rewards. I am still contacting our CSi-VIPs’ for their CSi-Legacy Shareholders Reports through all this, your time is limited, but it is still here until I’m done.
2. Congratulations to ALL our ‘CSi-VIP Investors’, over the years, your direct investments made the Key Financial changes required to push the CSi-Conglomerate GROUP of Companies over the hurdles, humps, and negativity before we even solidified our Success.
ENDO, CSi-Crypto, GBXI, and even TWCI, all potential and even announced acquisition and CSI-EDP Partners targeted and filtered through the Regulatory System with Success, Failures, and awaiting re-structured trading as well. Each Company will benefit TREMENDOUSLY from doing its part in the (CBIS/CSi) NASDAQ Trading Success and come back to trade under its own banner with the “CSi-Conglomerate GROUP of Companies” Success pushing them all forward. FINAL Structures will be announced during new regulatory filings procedures.
3. Congratulations to ALL our ‘CSi-GIFT Shareholders’, and ‘Original CBIS Shareholders’ you’ve been with us over the years, some form the beginning, 10+ years strong, enduring the good, the bad, and the ugly, the ups and downs, the negativity and sabotage ALL while continuing to push the Company forward with Your SUPPORT through it all. Now, we are here, and your perseverance has paid-off. Congrats!
We are working on another Official “1-Million Strong, VIP Fundraiser Event” News Release our Event Partner, Stainsforpains “EBYH”, will release as well to its shareholders and the general public. We will outline some exciting Event progress and release some structured time frames as to when we will announce the Venue, the Date, and the commencement of the ‘Official VIP Fundraiser Event Ticket Pre-Sales’.
There is a lot going on all at once right now, there is no doubt, and you can be sure we are up for the task. If we can go through what we’ve been through over the years killing cancers to get to this point, then there is no doubt. This here is a ‘CELEBRATION of our Success’ so ‘We Can Certainly Do This’.
We are building up the team with some Great individuals and Companies behind the scenes too to ensure an even bigger Success for us all.
All the Best Guys!
Stay Strong and God Bless.
Reach out with any Questions.
Talk soon - IGWT
Mr. Raymond C. Dabney
President & CEO, Chancellor
GBX International Group Inc., (GBXI)
American States University (ASU)
Cannabis Science Inc. (CSi-EDP)
Thermic Science (ENDO)
iCannabinoid (iCann)
raymond.dabney@cannabisscience.com
Show more